Search Results - "Janoschka, Claudia"
-
1
Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis
Published in Brain (London, England : 1878) (01-11-2019)“…Although the CNS is immune privileged, continuous search for pathogens and tumours by immune cells within the CNS is indispensable. Thus, distinct immune-cell…”
Get full text
Journal Article -
2
High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients
Published in Multiple sclerosis (01-09-2021)“…Background: Progressive multifocal leukoencephalopathy (PML) can in rare cases occur in natalizumab-treated patients with high serum anti-JCPyV antibodies,…”
Get full text
Journal Article -
3
Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study
Published in Frontiers in immunology (09-07-2018)“…Leukocyte sequestration is an established therapeutic concept in multiple sclerosis (MS) as represented by the trafficking drugs natalizumab (NAT) and…”
Get full text
Journal Article -
4
RGS2 drives male aggression in mice via the serotonergic system
Published in Communications biology (11-10-2019)“…Aggressive behavior in our modern, civilized society is often counterproductive and destructive. Identifying specific proteins involved in the disease can…”
Get full text
Journal Article -
5
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response
Published in Therapeutic advances in neurological disorders (01-01-2023)“…Background: Cladribine is a highly effective immunotherapy that is applied in two short-term courses over 2 years and reduces relapse rate and disease…”
Get full text
Journal Article -
6
Back to the roots - from Phenotype to Genotype in Monozygotic Twins discordant for Multiple Sclerosis“ (P1-1.Virtual)
Published in Neurology (03-05-2022)“…Abstract only…”
Get full text
Journal Article -
7
Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis
Published in The Journal of experimental medicine (07-11-2022)“…Epstein-Barr virus (EBV) infection precedes multiple sclerosis (MS) pathology and cross-reactive antibodies might link EBV infection to CNS autoimmunity. As an…”
Get full text
Journal Article -
8
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
Published in Brain (London, England : 1878) (07-05-2021)“…A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent…”
Get full text
Journal Article -
9
Immune signatures of prodromal multiple sclerosis in monozygotic twins
Published in Proceedings of the National Academy of Sciences - PNAS (01-09-2020)“…The tremendous heterogeneity of the human population presents a major obstacle in understanding how autoimmune diseases like multiple sclerosis (MS) contribute…”
Get full text
Journal Article -
10
Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity
Published in Brain (London, England : 1878) (29-11-2021)“…Dimethyl fumarate, an approved treatment for relapsing-remitting multiple sclerosis, exerts pleiotropic effects on immune cells as well as CNS resident cells…”
Get full text
Journal Article -
11
Dietary wheat amylase trypsin inhibitors exacerbate CNS inflammation in experimental multiple sclerosis
Published in Gut (01-01-2024)“…Wheat has become a main staple globally. We studied the effect of defined pro-inflammatory dietary proteins, wheat amylase trypsin inhibitors (ATI), activating…”
Get more information
Journal Article -
12
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound
Published in Proceedings of the National Academy of Sciences - PNAS (03-01-2023)“…After natalizumab (NAT) cessation, some multiple sclerosis (MS) patients experience a severe disease rebound. The rebound pathophysiology is still unclear;…”
Get full text
Journal Article -
13
Dimethyl fumarate treatment alters T cell metabolism in multiple sclerosis (1142)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
14
Correction: Broader Epstein–Barr virus–specific T cell receptor repertoire in patients with multiple sclerosis
Published in The Journal of experimental medicine (07-11-2022)Get full text
Journal Article -
15
Long-term natalizumab treatment enhances the pathogenic signature of Th17 cells – potential implications for treatment cessation? (P2.408)
Published in Neurology (18-04-2017)“…Abstract only…”
Get full text
Journal Article -
16
B7-H1 shapes T-cell–mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity
Published in Proceedings of the National Academy of Sciences - PNAS (11-10-2016)“…Molecular mechanisms that determine lesion localization or phenotype variation in multiple sclerosis are mostly unidentified. Although transmigration of…”
Get full text
Journal Article -
17
Immune Cell Profiling during Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of non-T Cell Populations into the CSF – Results from the ToFingo Successor Study (S52.002)
Published in Neurology (10-04-2018)“…Abstract only…”
Get full text
Journal Article -
18
Dimethyl Fumarate Treatment alters T Cell Metabolism in Multiple Sclerosis (P1.414)
Published in Neurology (10-04-2018)“…Abstract only…”
Get full text
Journal Article -
19
RGS2 drives male aggression in mice via the serotonergic system
Published in Communications biology (11-10-2019)“…Aggressive behavior in our modern, civilized society is often counterproductive and destructive. Identifying specific proteins involved in the disease can…”
Get full text
Journal Article